Hydrochlorothiazide

hydrochlorothiazide
(hye droe klor oh thye' a zide)

Apo-Hydro (CAN), Esidrix, Ezide, HydroDIURIL, Microzide Capsules, Novo-
Hydrazide (CAN), Oretic, Urozide (CAN)
Pregnancy Category B
Drug class
Thiazide diuretic
Therapeutic actions
Inhibits reabsorption of sodium and chloride in distal renal tubule, increasing the
excretion of sodium, chloride, and water by the kidney.
Indications
• Adjunctive therapy in edema associated with CHF, cirrhosis, corticosteroid, and
estrogen therapy; renal dysfunction
• Hypertension as sole therapy or in combination with other antihypertensives
• Unlabeled uses: Calcium nephrolithiasis alone or with amiloride or allopurinol to
prevent recurrences in hypercalciuric or normal calciuric patients; diabetes
insipidus, especially nephrogenic diabetes insipidus; osteoporosis
Contraindications and cautions

• Contraindicated with allergy to thiazides, sulfonamides; fluid or electrolyte
imbalance; renal disease (can lead to azotemia); liver disease (risk of hepatic
coma); anuria.
• Use cautiously with gout (risk of attack); SLE; glucose tolerance abnormalities,
diabetes mellitus; hyperparathyroidism; manic-depressive disorder (aggravated by
hypercalcemia); pregnancy; lactation.
Available forms
Tablets—25, 50, 100 mg; solution—50 mg/5 mL; capsules—12.5 mg
Dosages
ADULTS
• Edema: 25–200 mg daily PO until dry weight is attained. Then, 25–100 mg daily
PO or intermittently, up to 200 mg/day.
• Hypertension: Starting dose, 12.5–50 mg PO. For maintenance, 25–100 mg daily.
• Calcium nephrolithiasis: 50 mg daily or bid PO.
PEDIATRIC PATIENTS
General guidelines: 2.2 mg/kg/day PO in 2 doses.
< 6 mo: Up to 3.3 mg/kg/day in 2 doses.
6 mo–2 yr: 12.5–37.5 mg/day in 2 doses.
2–12 yr: 37.5–100.0 mg/day in 2 doses.
Pharmacokinetics
Route Onset Peak Duration
Oral 2 hr 4–6 hr 6–12 hr
Metabolism: Hepatic; T1/2: 5.6–14.8 hr

Distribution: Crosses placenta; enters breast milk
Excretion: Urine
Adverse effects
• CNS: Dizziness, vertigo, paresthesias, weakness, headache, drowsiness, fatigue,
leukopenia, thrombocytopenia, agranulocytosis, aplastic anemia, neutropenia
• CV: Orthostatic hypotension, venous thrombosis, volume depletion, cardiac
arrhythmias, chest pain
• Dermatologic: Photosensitivity, rash, purpura, exfoliative dermatitis, hives,
alopecia
• GI: Nausea, anorexia, vomiting, dry mouth, diarrhea, constipation, jaundice,
hepatitis, pancreatitis
• GU: Polyuria, nocturia, impotence, loss of libido
• Other: Muscle cramps and muscle spasms, fever, gouty attacks, flushing, weight
loss, rhinorrhea
Interactions
Drug-drug
• Altered electrolytes with loop diueretics, amphotericin B, corticosteroids
• Increased neuromuscular blocking effects and respiratory depression with
nondepolarizing muscle relaxants
• Decreased absorption with cholestyramine, colestipol
• Increased risk of cardiac glycoside toxicity if hypokalemia occurs
• Increased risk of lithium toxicity
• Decreased effectiveness of antidiabetic agents
Drug-lab test
• Decreased PBI levels without clinical signs of thyroid disturbance
Nursing considerations
Assessment
• History: Allergy to thiazides, sulfonamides; fluid or electrolyte imbalance; renal
or liver disease; gout; SLE; glucose tolerance abnormalities, diabetes mellitus;
hyperparathyroidism; manic-depressive disorders; lactation, pregnancy
• Physical: Skin color, lesions, edema; orientation, reflexes, muscle strength;
pulses, baseline ECG, BP, orthostatic BP, perfusion; R, pattern, adventitious
sounds; liver evaluation, bowel sounds, urinary output patterns; CBC, serum
electrolytes, blood glucose, liver and renal function tests, serum uric acid,
urinalysis
Interventions
• Give with food or milk if GI upset occurs.
• Mark calendars or provide other reminders of drug for alternate day or 3–5
days/wk therapy.
• Reduce dosage of other antihypertensives by at least 50% if given with thiazides;
readjust dosages gradually as BP responds.
• Administer early in the day so increased urination will not disturb sleep.
• Measure and record weights to monitor fluid changes.
Teaching points
• Record intermittent therapy on a calendar, or use prepared, dated envelopes. Take
drug early so increased urination will not disturb sleep. Drug may be taken with
food or meals if GI upset occurs.
• Weigh yourself on a regular basis, at the same time and in the same clothing;
record weight on your calendar.
• These side effects may occur: Increased volume and frequency of urination;
dizziness, feeling faint on arising, drowsiness (avoid rapid position changes;
hazardous activities, like driving; and alcohol); sensitivity to sunlight (use
sunglasses, wear protective clothing, or use a sunscreen); decrease in sexual
function; increased thirst (suck on sugarless lozenges and use frequent mouth
care).
• Report weight change of more than 3 lb in 1 day, swelling in your ankles or
fingers, unusual bleeding or bruising, dizziness, trembling, numbness, fatigue,
muscle weakness or cramps.
Adverse effects in Italic are most common; those in Bold are life-threatening.

Hydrochlorothiazide

Uploaded by

Copyright:

Available Formats

Hydrochlorothiazide

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Hydrochlorothiazide

Uploaded by

Copyright:

Available Formats

hydrochlorothiazide

(hye droe klor oh thye' a zide)

Contraindications and cautions

Metabolism: Hepatic; T1/2: 5.6–14.8 hr

You might also like